Stratos Wealth Partners, Ltd. Clovis Oncology, Inc. Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$11.63 - $32.67 $93 - $261	-8 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$29.37 - $49.48 $234 - $395	8 New	8 $0
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $336 - $499	-8 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$50.12 - $67.72 $400 - $541	8 New	8 $0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.